Assenagon Asset Management S.A. - CARDIFF ONCOLOGY INC ownership

CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 59 filers reported holding CARDIFF ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.

Quarter-by-quarter ownership
Assenagon Asset Management S.A. ownership history of CARDIFF ONCOLOGY INC
ValueSharesWeighting
Q3 2023$117,138
-44.1%
84,272
-40.8%
0.00%
-100.0%
Q2 2023$209,369
-67.9%
142,428
-63.9%
0.00%
-50.0%
Q1 2023$651,740
+259557.4%
394,994
+120.0%
0.00%
+100.0%
Q4 2022$251
-99.9%
179,543
+7.8%
0.00%0.0%
Q3 2022$256,000
-24.9%
166,534
+7.3%
0.00%0.0%
Q2 2022$341,000
-57.6%
155,190
-52.2%
0.00%
-50.0%
Q1 2022$805,000
+362.6%
324,460
+1140.0%
0.00%
+100.0%
Q2 2021$174,00026,1670.00%
Other shareholders
CARDIFF ONCOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
ELKHORN PARTNERS LIMITED PARTNERSHIP 45,000$630.04%
FinDec Wealth Services, Inc. 16,000$22,2400.02%
DENVER WEALTH MANAGEMENT, INC. 18,235$25,3470.02%
Atom Investors LP 18,298$25,4340.01%
Laurion Capital Management LP 722,100$1,003,7190.01%
MAI Capital Management 224,749$312,4010.01%
Callan Capital, LLC 31,147$43,2940.01%
GSA CAPITAL PARTNERS LLP 25,975$360.00%
Tortoise Investment Management, LLC 15,000$20,8500.00%
America First Investment Advisors, LLC 4,000$5,5600.00%
View complete list of CARDIFF ONCOLOGY INC shareholders